Go-Live: Tuesday 12 May 2020 | Time 14:00-14:40 (BST)
In Europe, the demand for EFSA-approved health claims associated with immune health is at an all-time high, with many brands looking to do quick launches of simpler products, while others are developing innovative formulations with a longer-term strategy that supports brand development and builds customer loyalty. Regulatory bodies and public health institutions also recognise the consumer demand, and are working to ensure shoppers have the information they need to make informed decisions about products that can optimise their immune health.
There is an overlap of information about what to take, who to buy from and how to understand claims that could easily overwhelm or confuse consumers. Instead, brands have the opportunity to improve messaging to cut through the noise and differentiate their brand value. Further, innovative ingredients with clinical substantiation are available to product developers looking for the ability to offer new products—many with unique delivery forms—that can address consumer desires. Discover the market opportunities and supplier insights supporting this growth.
Presentations in this webinar:
Immune balance: The compelling link between HRB probiotics and the immune system
How do HRB probiotics benefit immunity? Here’s the science
As the coronavirus COVID-19 pandemic evolves exponentially, consumer concerns about immunity are understandably heightened at this time. Immunity is the main mechanism of host defence against infectious agents. A healthy and well-balanced immune system could not only reduce the risk of getting viral and bacterial infections but also promote lifelong wellness. Probiotics have emerged as candidates for improving immune health. However, not all probiotics have the same immune-modulating activity and the effects are strain-specific and residential origin-dependent. In this webinar you will learn what aspects of Morinaga Human-Residential Bifidobacteria (HRB) strains can support immune health throughout human lifespan based on the clinical evidence available at this stage.
Why should you attend?
- Gain insights into the reasons Human-Residential Bifidobacteria (HRB) are the natural inhabitants of human gut
- Walk away with the connection between HRB probiotics and immunity
- Learn the science behind Morinaga HRB probiotic strains on immune health in people from all walks of life
Dr. Chyn Boon Wong
Morinaga Milk Industry Co., Ltd., Japan.
Based in the Tokyo headquarters, Chyn Boon is in charge of marketing activities related to global B2B businesses on Morinaga’s HRB probiotics. With rich research experience and strong scientific background, Chyn Boon is dedicated to turn groundbreaking research into successful business opportunities. She joined Morinaga Milk in 2016, as a research scientist, where she was involved in fundamental science and pre-clinical studies on bifidobacteria. Her research interests focus on understanding the roles of Human-Residential Bifidobacteria (HRB) as members of the human gut microbiota and exploring their new functional benefits on human health. Chyn Boon holds a PhD in Bioprocess Technology discovering the new health potentials of probiotics lactobacilli and their bioactive metabolites on skin health. Her postgraduate career has since focused on the health-promoting effects of beneficial microbes have on humans.
Answer increasing demand on time and distance your brand from the noise
Launching credible immunity supplements to stand out and succeed consistently
Many of you are wondering how to address the increasing demand for immunity supplements quickly enough and to stand out from the current crowd. What type of products to launch to not damage your brand image and succeed for longer than a few months? We won’t pretend we have a universal recipe for success, but what we can present is our line of clinically supported private label products and how our partners are succeeding with it in the market. Consistently. If you have a brand that is looking to challenge the market, you should attend.
Why should you attend?
- Meet our line of clinically supported immunity supplements - acute and preventive
- Understand why they stand out and are successful in such different markets
- Learn 5 key points that enabled our partners an advantage and stable sales
- Walk away with specific new product launch strategies
Science & Research Director
Science & Research Director at PharmaLinea. Coming from a rich academic background in biotechnology, biochemistry, and structural biology, Orešnik began her industry career in nutritionism and medical safety. Having developed an interest in research and development connected to human health, she joined PharmaLinea and has since overseen the development of the majority of PharmaLinea’s portfolio as well as several clinical trials.